Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DesiRTA

Financiado

Localize and Controlled co-delivery of AuNPs conjugated siRNA by Cationic Shear-...

Localize and Controlled co-delivery of AuNPs conjugated siRNA by Cationic Shear-thinning Gel Matrix for Treatment of Arthritis (DesiRTA) Arthritis is a common metabolic and immune associate disease that causes chronic pain and inflammation in a joint. Approximately 312 million people are affected by arthritis globally. It affects adults of all ages, both sexes, and... ver más

31/03/2026

UNIVERSITY OF LIME...

200K€

Presupuesto del proyecto: 200K€

Líder del proyecto

UNIVERSITY OF LIMERICK No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-03-30

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100% 100%

2 Participantes

UNIVERSITY OF LIMERICK

199.69K€ | Lider

UMINHO

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

IA-NANO Albumin particles for intra articular delivery of celecoxib... 197K€ Cerrado

SINPAIN A game changer for the treatment of osteoarthritis: a cost e... 5M€ Cerrado

grabRNA Smart RNA delivery for therapy and diagnostic 150K€ Cerrado

TraffikGene-Tx TraffikGene-Tx: Targeted Peptide Carriers for RNA Delivery 2M€ Cerrado

CTQ2016-75363-R DESARROLLO DE ESTRATEGIAS Y AGENTES TERAPEUTICOS INNOVADORES 105K€ Cerrado

NUEVAS FORMAS DE VEHICULIZACIÓN DE ANTIINFLAM... NUEVAS FORMAS DE VEHICULIZACIÓN DE ANTIINFLAMATORIOS EN CÁPS... 250K€ Cerrado

Duración del proyecto: 36 meses Fecha Inicio: 2023-03-30
Fecha Fin: 2026-03-31

Líder del proyecto

UNIVERSITY OF LIMERICK No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 200K€

Descripción del proyecto Arthritis is a common metabolic and immune associate disease that causes chronic pain and inflammation in a joint. Approximately 312 million people are affected by arthritis globally. It affects adults of all ages, both sexes, and all races and ethnicities, but the prevalence in women is more than in men. Professional organizations have established many arthritis treatment regimens and management guidelines; in those nonsteroidal anti-inflammatory drugs (NSAIDs), steroids and biologicals are the main ones. These are effective against the disease aggressiveness and pain up to some extent, but the problem is this treatment is only symptomatic and requires taking them lifelong; in that case, these drugs cause severe health problems and again increase the economic burden. For these reasons, we need to develop a therapeutic technique and medication that can eliminate the symptom and causes of the disease forever and prevent the ever-increasing number of patients worldwide. DesiTRA projects are an effort in the same vein to develop an effective therapeutic alternative for arthritis that will avoid the aggravation of disease symptoms and cause of the disease together, without causing any health-associated side effects. In this, mainly gold nanoparticle (AuNPs) conjugated siRNA will be delivered at the disease site locally. Modified polysaccharides will increase the stability and release rate of AuNPs-siRNA, and these assemblies will be delivered very controlled and precisely through a synovial fluid mimicking the shear-thinning hydrogel system. The ambitious project will be conducted at two different groups and laboratories in Ireland and Portugal. The project involves experienced researchers of other but related areas that will allow applicants to work in multidisciplinary aspects. The prestigious fellowship will provide a plate form of renowned subject experts, and exposure to international collaborators will provide a unique opportunity to grow as a true researcher

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores